Top rated 20 – EGT Fun

“, Onco Targets Therapy, Cilt 9, 5439–5450 pp., 2016.

Z.B. Cincin, M. Unlu, B. Kiran, E.S. Bireller, Y. Baran, B. Cakmakoglu, “Anti-proliferative, apoptotic and signal transduction effects of hesperidin in non-small cell lung cancer cells.”, Cellular Oncology, Cilt 38(3), 195-204 pp., 2015.

J. Zhao, X. Zhang, X. He, G. Yang, X. Zhang, W. Xin, H. Li, “Multidrug-Resistant Tuberculosis in Patients with Chronic Obstructive Pulmonary Disease in China.”, Plos One, https://doi.org/10.1371/journal.pone.0135205, 2015.

B. Kıran, T. Cagatay, P. Clark, F. Kosar, P. Cagatay, S. Yurt, F. Suzergoz ve A.O. Gurol, “Can immune parameters be used as a predictor to distinguish between pulmonary multi-drug resistant and drug sensitive tuberculosis?”, Archives of Medical Science (Arch Med Sci ) (ISI) , Cilt 6,1, 77-82 pp., 2010.

H. Shen, R. Min, Q. Tan, W. Xie, H. Wang, H. Pan, L. Zhang, H. Xu, X. Zhang, J. Da, “The beneficial effects of adjunctive recombinant human interleukin-2 for multidrug resistant tuberculosis.”, Archives of Medical Science (Arch Med Sci ) (ISI) , Cilt 11(3), 584–590 pp., 2015.

B. Kıran, T. Cagatay, P. Clark, F. Kosar, P. Cagatay, S. Yurt, F. Suzergoz ve A.O. Gurol, “Can immune parameters be used as a predictor to distinguish between pulmonary multi-drug resistant and drug sensitive tuberculosis?”, Archives of Medical Science (Arch Med Sci ) (ISI) , Cilt 6,1, 77-82 pp., 2010.

H. Iguchi, “Recent aspects for disseminated carcinomatosis of the bone marrow associated with gastric cancer: What has been done for the past, and what will be needed in future?”, WORLD JOURNAL OF GASTROENTEROLOGY, Cilt 21(43), 12249–12260 pp., 2015.

N. Cabioglu, A. Sahin, M. Doucet, E. Yavuz, A. Igci, EO. Yildirim, E. Aktas, S. Bilgic, B. Kiran, G. Deniz, JE. Price, “Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow”, Clinical Experimental Metastasis (ISI) , Cilt 22(1), 39-46 pp., 2005.

H. Wu, L. Zhu, H. Zhang, X. Shi, L. Zhang, W. Wang, H. Xue, Z. Liang, “Coexpression of EGFR and CXCR4 Predicts Poor Prognosis in Resected Pancreatic Ductal Adenocarcinoma.”, Plos One, https://doi.org/10.1371/journal.pone.0116803, 2015.

N. Cabioglu, A. Sahin, M. Doucet, E. Yavuz, A. Igci, EO. Yildirim, E. Aktas, S. Bilgic, B. Kiran, G. Deniz, JE. Price, “Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow”, Clinical Experimental Metastasis (ISI) , Cilt 22(1), 39-46 pp., 2005.

A. Yuan, Y. Lee, U. Choi, G. Moeckel, A. Karihaloo, “Chemokine receptor Cxcr4 contributes to kidney fibrosis via multiple effectors.

unappropriated4

Leave a Reply

Your email address will not be published. Required fields are marked *